mTOR信号通路调节 HIF-1 α 对LPS诱导的肠粘膜上皮损伤模型的影响
Zeyong Huang1, Wenbin Teng2, Liuxu Yao3
1Department of Anesthesiology, Shulan (Hangzhou) Hospital, Shulan International Medical College, Zhejiang Shuren College, 310015, Hangzhou, China.
BMC molecular and cell biology
|April 23, 2024
概括
缺氧诱导因子1-alpha (HIF-1α) 通过保持表皮屏障完整性来保护免受败血症引起的肠损伤. 这项研究证实了HIF-1α通过P70S6K信号通路的保护作用.
科学领域:
- 细胞生物学 细胞生物学
- 胃肠病学 胃肠病学
- 疾病的分子机制.
背景情况:
- 败血症经常导致小肠损伤,增加患者的死亡率.
- 以前的研究表明,缺氧诱导因子1-alpha (HIF-1α) 在败血症模型中提供了对肠道粘膜损伤的保护.
- 这项研究旨在进一步验证HIF-1α的保护作用,并阐明其在体外的分子机制.
研究的目的:
- 在体外模型中研究HIF-1α在败血症引起的肠上皮损伤中的保护作用.
- 探索HIF-1α影响肠上皮质屏障功能的分子机制.
- 检查HIF-1α和mTOR信号通路在调节肠道上皮质完整性的相互作用.
主要方法:
- 用脂多糖 (LPS) 刺激Caco-2细胞以模仿败血症状况.
- 评估了HIF-1α激活剂和抑制剂对LPS诱导的Caco-2细胞损伤的影响.
- 通过途径激活剂和抑制剂,研究了mTOR信号通路在调解HIF-1α的保护作用中的作用.
主要成果:
- 激活HIF-1α降低了肠道上皮的透性,并增加了紧结蛋白的表达.
- HIF-1α抑制加剧了LPS诱导的Caco-2细胞损伤.
- mTOR通路激活与HIF-1α水平相关,这表明存在调节关系.
结论:
- 在败血症模型中,HIF-1α显著减轻了肠上皮屏障的损伤.
- 这种保护机制涉及P70S6K信号通路.
- 未来的研究应该探索HIF-2α在肠上皮质屏障调节中的作用.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K


